BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Oral Microbiome and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer
- Status
- TERMINATED
- Phase
- PHASE2
VM110 in Detection of Microscopic Tumors: A Phase I Study
- Status
- TERMINATED
- Phase
- PHASE1
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
- Status
- COMPLETED
- Phase
- PHASE3
Margin Status After Pancreaticoduodenectomy for Cancer
- Status
- COMPLETED
- Phase
- NA
Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery
- Status
- TERMINATED
- Phase
- NA
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- NA
Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia
- Status
- COMPLETED
- Phase
- PHASE1
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Study to Evaluate G17DT Compared to Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE3